Shaomei Tang

Shaomei Tang

Auto-generated profile, based on publicly available information

Shaomei Tang

Department of Gastroenterology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
QLQinchen Lu
Qinchen Lu
JGJiamin Gao
Jiamin Gao
STShaomei Tang
Shaomei Tang
ZLZhijian Li
Zhijian Li
XWXi Wang
Xi Wang
QWqiuyan wang
qiuyan wang
Purpose: Accumulating evidence indicates that long non-coding RNAs (lncRNAs) play critical roles in the development of many cancer types. However, the changes of lncRNAs expression profiles in hepatocarcinogenesis remain largely unknown. Therefore, the purpose of this study was to identify the clinical significance, oncogenic functions, and potential mechanism of cancer-related lncRNAs in hepatocellular carcinoma (HCC). Materials and Methods: An in vitro hepatocellular carcinoma model was established via oncogene-mediated transformation with a combination of three genetic alterations, including hTERT overexpression, inactivation of P53, and KRAS activation. Changes of biological function and transcriptome profile in these cell lines were determined by colony formation assay, MTT assay, wound-healing scratch assay, xenograft nude mice model, mass cytometry and RNA sequencing (RNA-Seq). Furthermore, 116 HCC tissues and its corresponding normal tumor-adjacent tissues were explored to validate the results of cell lines. Finally, RNA sequencing, single-cell mass cytometry and fluorescence-activated cell sorter were applied to evaluate the potential association between the expression of lncRNA and the stemness of HCC. Results: LncRNA HOXA-AS2 was aberrantly upregulated and it may be involved in the regulation of cancer stem cells during oncogenic transformation. Consistently, lncRNA HOXA-AS2 expression was significantly upregulated in HCC and its higher expression positively correlated with poor prognosis and stem cell-related functions. Moreover, a specific cancer stem cell subpopulation with EPCAM+, C-MYC+ and CK19+ may exist in higher HOXA-AS2 expression HCC patients. Conclusion: LncRNA HOXA-AS2 plays pivotal roles in the occurrence and progression of HCC, which may act as a therapeutic target for prognostic biomarker in hepatocellular carcinoma.

1 October 2018 in Gene
Verified
Journal Article
Closed access
CDCaiwang Deng
Caiwang Deng
STShaomei Tang
Shaomei Tang
XHXiaoliang Huang
Xiaoliang Huang
JGJiamin Gao
Jiamin Gao
JTJiarong Tian
Jiarong Tian
QWQiuyan Wang
Qiuyan Wang

1 July 2021 in Clinics and Research in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
QHQing-Lin He
Qing-Lin He
XCXiu-Bing Chen
Xiu-Bing Chen
DLDong-Hong Lu
Dong-Hong Lu
WLWei Luo
Wei Luo
LTLin Tao
Lin Tao
HJhaixing jiang
haixing jiang

19 February 2021 in Research Square
Verified
Preprint
Open access
PDF file
STShaomei Tang
Shaomei Tang
XHXiaoliang Huang
Xiaoliang Huang
HJHaixing Jiang
Haixing Jiang
SQShanyu Qin
Shanyu Qin
The authors have requested that this preprint be removed from Research Square.